Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The DISARM study: effects of inhaled corticosteroids on bronchial epithelial cell gene expression in COPD

ABSTRACT: The DISARM study: effects of inhaled corticosteroids on bronchial epithelial cell gene expression in COPD

PROVIDER: PRJNA680616 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13130600_1.fastq.gz	Fastqsanger.gz
	SRR13130600_2.fastq.gz	Fastqsanger.gz
	SRR13130700_1.fastq.gz	Fastqsanger.gz
	SRR13130700_2.fastq.gz	Fastqsanger.gz
	SRR13130800_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 944

Similar Datasets

The DISARM study: effects of inhaled corticosteroids on bronchial epithelial cell gene expression in COPD

Project description:The Differential Effects of Inhaled Symbicort and AdvaiR on Lung Microbiota (DISARM) study aimed to determine the effects of inhaled corticosteroids (ICS) on the lung microbiome. The full trial protocol is registered at clinicaltrials.gov (NCT02833480) and the study was approved by the Human Research Ethics Committee of the University of British Columbia and Providence Health Care (H14-02277). Participants were randomized to receive inhaled long-acting beta agonist (LABA) treatment with formoterol, or LABA/ICS combination treatment with formoterol/budesonide or salmeterol/fluticasone propionate, for 12 weeks. Bronchoscopy was performed before and after treatment, and bronchoalveolar lavage fluid and bronchial brushes (6th-8th generation) were collected. This dataset contains RNA-seq data from the bronchial brushes. RNA was extracted from cytological brush specimens stored in QIAzol RNA lysis buffer (QIAGEN, Stockach, Germany) using the RNeasy Plus kit (QIAGEN) according to the manufacturer’s instructions, and specimens were submitted for sequencing at the University of British Columbia Biomedical Research Centre. Sample quality control was performed using the Agilent 2100 Bioanalyzer (Agilent, Santa Clara, CA, USA). Qualifying samples were then prepared following the standard protocol for the NEBnext Ultra ii Stranded mRNA (New England Biolabs, Ipswich, MA, USA). Sequencing was performed on the Illumina NextSeq 500 (Illumina, San Diego, CA, USA) with paired end 42bp × 42bp reads. Samples were sequenced in batches of 24, with batches formed by random selection of samples.

2021-03-22 | GSE162120 | GEO

The effects of inhaled corticosteroids on healthy airways

Project description:The effects of inhaled corticosteroids on healthy airways

| PRJNA1011266 | ENA

RNA sequencing of human bronchial epithelial cell transcriptomes after repopulation and differentiation on bronchial scaffolds from COPD patients and healthy donors

Project description:Chronic obstructive pulmonary disease (COPD) is a serious global health problem characterized by chronic airway inflammation, progressive airflow limitation and destruction of lung parenchyma. Remodeling of the bronchial airways in COPD includes changes in both the bronchial epithelium and the subepithelial extracellular matrix (ECM). To explore the impact of an aberrant ECM on epithelial cell phenotype in COPD we developed a new ex vivo model, in which normal human bronchial epithelial (NHBE) cells repopulate and differentiate on decellularized human bronchial scaffolds derived from COPD patients and healthy individuals. By using transcriptomics, we show that bronchial ECM from COPD patients induces differential gene expression in primary NHBE cells when compared to normal bronchial ECM. The gene expression profile indicated altered activity of upstream mediators associated with COPD pathophysiology, including hepatocyte growth factor, transforming growth factor beta 1 and platelet-derived growth factor B, which suggests that COPD-related changes in the bronchial ECM contribute to the defective regenerative ability in the airways of COPD patients.

2018-02-20 | GSE107971 | GEO

Proteomic effects of budesonide and imiquimod on human bronchial epithelial cells

Project description:We carry out a comparative proteomic analysis of human bronchial epithelial cells from patients clinically treated or not with inhaled budesonide and stimulated or not with the viral mimic Poly(I:C).We also wanted to investigate the potential anti-viral effects of imiquimod, a TLR7 agonist, on the bronchial epithelial cells proteome in vitro.

2021-11-22 | PXD029135 | Pride

Transcriptome analysis of primary bronchial epithelial cells from healthy, ex-smoker COPD and current smoker COPD patients cultured in ALI conditions

Project description:Transcriptome analysis of primary bronchial epithelial cells from healthy, ex-smoker COPD and current smoker COPD patients cultured in ALI conditions

2026-04-29 | GSE301910 | GEO

Single cell RNAseq of primary bronchial epithelial cells from healthy, ex-smoker COPD and current smoker COPD patients cultured in ALI conditions

Project description:Single cell RNAseq of primary bronchial epithelial cells from healthy, ex-smoker COPD and current smoker COPD patients cultured in ALI conditions

2026-04-29 | GSE302794 | GEO

Single cell ATACseq of primary bronchial epithelial cells from healthy, ex-smoker COPD and current smoker COPD patients cultured in ALI conditions

Project description:Single cell ATACseq of primary bronchial epithelial cells from healthy, ex-smoker COPD and current smoker COPD patients cultured in ALI conditions

2026-04-29 | GSE302411 | GEO

ATAC-seq analysis of primary bronchial epithelial cells from healthy, ex-smoker COPD and current smoker COPD patients cultured in ALI conditions

Project description:ATAC-seq analysis of primary bronchial epithelial cells from healthy, ex-smoker COPD and current smoker COPD patients cultured in ALI conditions

2026-04-29 | GSE302115 | GEO

The effects of inhaled corticosteroids on healthy airways

Project description:The effects of inhaled corticosteroids (ICS) on healthy airways are poorly defined. Our objective was to delineate the effects of ICS on gene expression in healthy airways, without confounding caused by changes in disease-related genes and disease-related alterations in ICS-responsiveness. We performed a randomised open-label bronchoscopy study of high dose ICS therapy in 30 healthy adult volunteers randomised 2:1 to i) fluticasone propionate 500 mcg bd or ii) no treatment (control), for 4 weeks. Laboratory staff were blinded to allocation. Biopsies and brushings were analysed by bulk RNA sequencing. ICS treatment upregulated 72 genes in brushings and 53 genes in biopsies, and downregulated 82 genes in brushings and 416 genes in biopsies. The most downregulated genes in both tissues were canonical markers of type-2 inflammation (FCER1A, CPA3, IL33, CLEC10A, SERPINB10 and CCR5), T cell-mediated adaptive immunity (TARP, TRBC1, TRBC2, PTPN22, TRAC, CD2, CD8A, HLA-DQB2, CD96, PTPN7), B cell immunity (CD20, immunoglobulin heavy and light chains), and innate immunity, including CD48, Hobit, RANTES, Langerin and GFI1. An IL-17-dependent gene signature was not upregulated by ICS. In healthy airways, 4-week ICS exposure reduces gene expression related to both innate and adaptive immunity, and reduces markers of type-2 inflammation. This implies that homeostasis in health involves tonic type-2 signalling in the airway mucosa, which is exquisitely sensitive to ICS.

2024-08-08 | GSE242048 | GEO

Microbiome Use to Stratify use of Inhaled Corticosteroids (MUSIC)Trial

Project description:Investigating the mechanism of inhaled corticosteroids associated pneumonia by longitudinal characterisation of the airway microbiome in patients with severe COPD.

| PRJEB62885 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data